 Connection
Mir Ali to Opioid-Related Disorders
This is a "connection" page, showing publications Mir Ali has written about Opioid-Related Disorders.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
3.678 |
|
|
|
-
Ali MM, Creedon TB, Jacobus-Kantor L, Sherry TB. National trends in buprenorphine prescribing before and during the COVID-19 pandemic. J Subst Abuse Treat. 2023 01; 144:108923.
Score: 0.539
-
Ali MM, Dubenitz J. Suicidal behavior, opioid use disorder, and behavioral health treatment: Prevalence and correlates among adults in the United States 2015-2018. J Subst Abuse Treat. 2021 11; 130:108413.
Score: 0.485
-
Meinhofer A, Hinde JM, Ali MM. Substance use disorder treatment services for pregnant and postpartum women in residential and outpatient settings. J Subst Abuse Treat. 2020 03; 110:9-17.
Score: 0.441
-
Ali MM, Tehrani AB, Mutter R, Henke RM, Cutler E, Pines JM, Mazer-Amirshahi M. Factors associated with potentially problematic opioid prescriptions among individuals with private insurance and medicaid. Addict Behav. 2019 11; 98:106016.
Score: 0.426
-
Ali MM, Cutler E, Mutter R, Henke RM, O'Brien PL, Pines JM, Mazer-Amirshahi M, Diou-Cass J. Opioid Use Disorder and Prescribed Opioid Regimens: Evidence from Commercial and Medicaid Claims, 2005-2015. J Med Toxicol. 2019 07; 15(3):156-168.
Score: 0.426
-
Ali MM, Henke RM, Mutter R, O'Brien PL, Cutler E, Mazer-Amirshahi M, Pines JM. Family member opioid prescriptions and opioid use disorder. Addict Behav. 2019 08; 95:58-63.
Score: 0.418
-
Jones CM, Olsen Y, Ali MM, Sherry TB, Mcaninch J, Creedon T, Juliana P, Jacobus-Kantor L, Baillieu R, Diallo MM, Thomas A, Gandotra N, Sokolowska M, Ling S, Compton W. Characteristics and Prescribing Patterns of Clinicians Waivered to Prescribe Buprenorphine for Opioid Use Disorder Before and After Release of New Practice Guidelines. JAMA Health Forum. 2023 07 07; 4(7):e231982.
Score: 0.141
-
West KD, Ali MM, Blanco M, Natzke B, Nguyen L. Prenatal Substance Exposure and Neonatal Abstinence Syndrome: State Estimates from the 2016-2020 Transformed Medicaid Statistical Information System. Matern Child Health J. 2023 Dec; 27(Suppl 1):14-22.
Score: 0.140
-
Sanmartin MX, Ali MM, Dwyer DS. Trends in buprenorphine-waivered providers in Medicaid expansion and non-expansion states by their public listing status. Subst Abus. 2022 12; 43(1):1072-1074.
Score: 0.136
-
Feder KA, Ali MM, Sherman LJ, Letourneau E, Barry CL, Stuart EA, Mutter R. Elevated prevalence of antisocial behavior in adolescent children whose mothers misuse opioids. Drug Alcohol Depend. 2020 10 01; 215:108153.
Score: 0.116
-
Sanmartin MX, McKenna RM, Ali MM, Krebs JD. Racial Disparities in Payment Source of Opioid Use Disorder Treatment among Non-Incarcerated Justice-Involved Adults in the United States. J Ment Health Policy Econ. 2020 Mar 01; 23(1):19-25.
Score: 0.112
-
McClellan C, Fingar KR, Ali MM, Olesiuk WJ, Mutter R, Gibson TB. Price elasticity of demand for buprenorphine/naloxone prescriptions. J Subst Abuse Treat. 2019 11; 106:4-11.
Score: 0.108
-
Novak P, Feder KA, Ali MM, Chen J. Behavioral health treatment utilization among individuals with co-occurring opioid use disorder and mental illness: Evidence from a national survey. J Subst Abuse Treat. 2019 03; 98:47-52.
Score: 0.103
-
Naeger S, Mutter R, Ali MM, Mark T, Hughey L. Post-Discharge Treatment Engagement Among Patients with an Opioid-Use Disorder. J Subst Abuse Treat. 2016 10; 69:64-71.
Score: 0.087
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|